TGA / PMDA / NMPA · Asia-Pacific
somapacitan — TGA / PMDA / NMPA regulatory status
somapacitan (SOGROYA) regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: NMPA clinical trials.
Status snapshot
- Status
- NMPA clinical trials
- Brand
- SOGROYA
- Mechanism
- Growth hormone receptor agonist
- Target
- Growth hormone receptor
- Structured fields
- 6
Pharmacology context used for competitive intelligence: Growth hormone receptor agonist. Target: Growth hormone receptor. This page is a status aggregation for professional reference — not prescribing advice.
Regional decision snapshot — NMPA: clinical trials.
Linked evidence on this spoke: 5 published clinical programs and 0 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| NMPA | China | clinical trials | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| NN8640-4263 | Phase 3 | NovoThirteen | 2023-506829-11-00 |
| NN8640-4467 | Phase 3 | NovoThirteen | 2023-506927-27-00 |
| Somapacitan | Phase 3 | Novo Nordisk A/S | NCT03811535, NCT04970654 |
| somapacitan | Phase 3 | Novo Nordisk A/S | NCT02229851 |
| NN8640-4245 | Phase 2 | NovoThirteen | 2023-506830-66-00 |
Related hubs
FAQ
What is the TGA / PMDA / NMPA approval status of somapacitan?
somapacitan currently shows NMPA clinical trials in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get somapacitan regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to somapacitan?
This spoke lists 5 published programs associated with somapacitan in our pipeline index.